article thumbnail

Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score

Psychiatric Times

of patients who were prescribed antipsychotics for their psychiatric illness and had evidence of tardive dyskinesia (TD) had TD recorded properly in their electronic health records, supporting the idea that TD is often underreported and misdiagnosed and, therefore, not treated appropriately. References 1. Griffiths K, Won Y, Lee Z, et al.

article thumbnail

Dismissing the “Human Experience”: College Students Feel Unseen by the Medical Model of Mental Health

Mad in America

In a previous story , I reported on the “TikTokification” of mental health —a phenomenon where social media content encourages young people to self-diagnose. Many students find comfort in the medical model of mental health because it simplifies experiences that are otherwise messy, uncomfortable, and difficult to make sense of. “I

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Psychiatric Times

1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.

article thumbnail

“There’s No Word for Depression in Zulu”: Inside South Africa’s Mental Health Crisis

Mad in America

R esearch has found South Africa consistently ranks in the bottom three performing countries in terms of global mental health. Photo by tuxone The Mental State of the World Report measures the mental health of internet users only, making it limited in the South African context where close to one-third of the population isnt online.

article thumbnail

How Do Psychiatry Residents Learn Psychopharmacology?

Psychiatric Times

Author(s): Joseph F. Goldberg, MD , Stephen M. Stahl, MD, PhD, DSc (Hon) Now more than ever, capturing and scaling the ingredients that make for compelling and impactful teaching for trainees is vital to our future. andrey_orlov/AdobeStock CLINICAL REFLECTIONS Medical education has traversed an evolving path over the past few decades.

Education 123
article thumbnail

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Psychiatric Times

The COMP005 trial is the first phase 3 study of synthetic psilocybin, marking a milestone in psychedelic research for mental health. We remain focused on our goal of transforming the landscape of mental health treatment.” Compass Pathways plans to engage with the FDA regarding these promising preliminary results.

article thumbnail

Redemption in Psychiatry

Psychiatric Times

There is an article about redeeming diagnosis, 1 but not much more that I know of. Our rally for mental health at the annual meeting began a redemption for what might be thought to be unnecessary societal passivity. Perhaps that critique is why we don’t hear hardly anything about redemption in psychiatry.